Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-005057
Filing Date
2021-03-04
Accepted
2021-03-04 19:32:34
Documents
1
Period of Report
2021-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 6763
  Complete submission text file 0001437749-21-005057.txt   8471
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONTRAVIR PHARMACEUTICALS, INC. 420 LEXINGTON AVE., SUITE 300 NEW YORK NY 10170
Business Address
Hornung William Karl (Reporting) CIK: 0001612066 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37942 | Film No.: 21716025